Brain Imaging Studies of Negative Reinforcement in Humans (R21)

The summary for the Brain Imaging Studies of Negative Reinforcement in Humans (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Brain Imaging Studies of Negative Reinforcement in Humans (R21): Purpose. This FOA issued by National Institute on Drug Abuse, National Institutes of Health, solicits Exploratory/Developmental Grant (R21) applications from institutions/ organizations that propose to investigate brain processes in humans underlying how aversive events control behavior in order to stimulate a program of clinical neuroscience research on negative reinforcement / avoidance learning.On the basis of pre-clinical studies, negative reinforcement has re-emerged as a contributing factor in the basic processes of substance abuse.The range of processes engaged by the human brain to avoid aversive outcomes are much less well understood than that of brain processes engaged by positive outcomes. For the purpose of this FOA negative reinforcement and avoidance learning are considered synonymous and refer to behaviors and cognitive strategies that are learned and maintained in order to minimize or eliminate the occurrence of aversive events. Aversive events may be either environmental stimuli or internal states. Applications for this FOA are expected to propose exploratory, hypotheses-generating or proof of concept studies regarding the brain regions or processes in humans that underlie avoidance learning including behaviors and cognitive strategies maintained by negative reinforcement. This FOA is also appropriate for the development of new tasks in humans that may be used in future brain imaging studies to target specific brain processing areas affected by negative reinforcement/avoidance learning. The studies proposed in response to this FOA may be conducted in healthy individuals, substance-abusing populations (current or abstinent) or individuals at risk for substance abuse.However, all applications must address how the proposed investigations are relevant to advancing the understanding of substance abuse.
Federal Grant Title: Brain Imaging Studies of Negative Reinforcement in Humans (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-09-009
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: Feb 19, 2009
Original Application Deadline: Feb 19, 2009
Posted Date: Nov 05, 2008
Creation Date: Nov 05, 2008
Archive Date: Mar 22, 2009
Total Program Funding: $3,000,000
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, An...
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
Research Networks for the Study of Recovery Support Services for Persons Treated with Medi...
The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowe...
The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020